State Street Health Care Select Sector SPDR ETF
XLV SectorUpdated: Apr 6, 2026, 12:07 UTC
Key Metrics
Top 10 Holdings
| Holding | Ticker | Weight | Bar |
|---|---|---|---|
| Eli Lilly and Co | LLY | 14.4% | |
| Johnson & Johnson | JNJ | 10.32% | |
| AbbVie Inc | ABBV | 7.07% | |
| Merck & Co Inc | MRK | 5.3% | |
| UnitedHealth Group Inc | UNH | 4.58% | |
| Amgen Inc | AMGN | 3.6% | |
| Abbott Laboratories | ABT | 3.49% | |
| Thermo Fisher Scientific Inc | TMO | 3.37% | |
| Gilead Sciences Inc | GILD | 3.19% | |
| Intuitive Surgical Inc | ISRG | 3.08% |
Sector Allocation
About This ETF
The State Street Health Care Select Sector SPDR ETF (XLV) is a Sector ETF with an expense ratio (TER) of 0.08% and $43.1B in assets under management., with its largest holdings being Eli Lilly and Co, Johnson & Johnson, AbbVie Inc. The ETF currently yields 1.55% in dividends. Year-to-date, XLV has returned -5.21%. With an expense ratio of just 0.08%, it is one of the cheapest ETFs in its category.
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Where can I buy XLV?
Compare the best brokers for ETF savings plans — low fees, trusted providers, fully regulated.